-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: keymaster@town.hall.org
Originator-Key-Asymmetric:
 MFkwCgYEVQgBAQICAgADSwAwSAJBALeWW4xDV4i7+b6+UyPn5RtObb1cJ7VkACDq
 pKb9/DClgTKIm08lCfoilvi9Wl4SODbR1+1waHhiGmeZO8OdgLUCAwEAAQ==
MIC-Info: RSA-MD5,RSA,
 hO+MMOXi5v/7qoUpI998dWsHpX2yXEvnrR34ploI/MS25BkErhrv+K4++g48QnFE
 Bz8yr80jo8v8ELKMC/CGRw==

<IMS-DOCUMENT>0000315066-94-000621.txt : 19940216
<IMS-HEADER>0000315066-94-000621.hdr.sgml : 19940216
ACCESSION NUMBER:		0000315066-94-000621
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		19940214

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UTAH MEDICAL PRODUCTS INC
		CENTRAL INDEX KEY:			0000706698
		STANDARD INDUSTRIAL CLASSIFICATION:	3841
		IRS NUMBER:				870342734
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		34
		SEC FILE NUMBER:	005-34115
		FILM NUMBER:		94508421

	BUSINESS ADDRESS:	
		STREET 1:		7043 S 300 WEST
		CITY:			MIDVALE
		STATE:			UT
		ZIP:			84047
		BUSINESS PHONE:		8015661200

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FMR CORP
		CENTRAL INDEX KEY:			0000315066
		STANDARD INDUSTRIAL CLASSIFICATION:	0000
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G

	BUSINESS ADDRESS:	
		STREET 1:		82 DEVONSHIRE ST
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02109
		BUSINESS PHONE:		6175706339
</IMS-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<DESCRIPTION>SCHEDULE 13G - 2-14-94 - UTAH MEDICAL PRODUCTS
INCORPORATED
<TEXT>



SCHEDULE 13G

Amendment No.
Utah Medical Products Incorporated
common stock
Cusip # 917488108
Filing Fee: Yes


Cusip # 917488108
Item 1:   Reporting Person - FMR Corp. - (Tax ID:  04-2507163)
Item 4:   Commonwealth of Massachusetts
Item 5:   None
Item 6:   None
Item 7:   830,830
Item 8:   None
Item 9:   830,830
Item 11:  7.29%
Item 12:  HC 




Cusip # 917488108
Item 1:   Reporting Person - Edward C. Johnson 3d - (Tax ID: 
###-##-####)
Item 4:   United States of America
Item 5:   None
Item 6:   None
Item 7:   830,830
Item 8:   None
Item 9:   830,830
Item 11:  7.29%
Item 12:  IN 




SCHEDULE 13G - TO BE INCLUDED IN STATEMENTS
FILED PURSUANT TO RULE 13d-1(b) or 13d-2(b)


Item 1(a).    Name of Issuer:

         Utah Medical Products Incorporated

Item 1(b).    Name of Issuer's Principal Executive Offices:

         7043 South 300 West
         Midvale, UT  84047

Item 2(a).    Name of Person Filing: 

         FMR Corp.

Item 2(b).    Address or Principal Business Office or, if None,
Residence:

         82 Devonshire Street, Boston, Massachusetts  02109

Item 2(c).    Citizenship:

         Not applicable

Item 2(d).    Title of Class of Securities:

         Common Stock

Item 2(e).    CUSIP Number:  

         917488108

Item 3.  This statement is filed pursuant to Rule 13d-1(b) or 13d-
2(b) and the person filing, FMR Corp., is a parent
holding company in accordance with Section 240.13d-
1(b)(ii)(G).  (Note:  See Item 7).

Item 4.  Ownership

         (a)  Amount Beneficially Owned:    830,830

         (b)  Percent of Class:   7.29%

         (c)  Number of shares as to which such person has:  

              (i)   sole power to vote or to direct the vote:
    None

              (ii)  shared power to vote or to direct the vote:
    None

              (iii) sole power to dispose or to direct the
disposition of:    830,830

              (iv)  shared power to dispose or to direct the
disposition of:    None




Item 5.  Ownership of Five Percent or Less of a Class.

         Not applicable.

Item 6.  Ownership of More than Five Percent on Behalf of
Another Person.

         Various persons have the right to receive or the
power to direct the receipt of dividends from, or
the proceeds from the sale of, the common stock of
Utah Medical Products Incorporated.  No one
person's interest in the common stock of Utah
Medical Products Incorporated is more than five
percent of the total outstanding common stock.

Item 7.  Identification and Classification of the Subsidiary
Which Acquired the Security Being Reported on By the
Parent Holding Company.

         See attached Exhibit(s) A and B.

Item 8.  Identification and Classification of Members of the
Group.

         Not applicable, see attached Exhibit A. 

Item 9.  Notice of Dissolution of Group.

         Not applicable.


Item 10. Certification.

         By signing below I certify that, to the best of my
knowledge and belief, the securities referred to above
were acquired in the ordinary course of business and
were not acquired for the purpose of and do not have
the effect of changing or influencing the control of
the issuer of such securities and were not acquired in
connection with or as a participant in any transaction
having such purpose or effect.


Signature

         After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information
set forth in this statement is true, complete and
correct. 



    February 11, 1994   
Date



    /S/Arthur S. Loring
Signature



    Arthur S. Loring, Vice
President     
Name/Title




SCHEDULE 13G - TO BE INCLUDED IN STATEMENTS
FILED PURSUANT TO RULE 13d-1(b) or 13d-2(b)

    Pursuant to the instructions in Item 7 of Schedule 13G,
Fidelity Management & Research Company ("Fidelity"), 82
Devonshire Street, Boston, Massachusetts 02109, a wholly-owned
subsidiary of FMR Corp. and an investment adviser registered
under Section 203 of the Investment Advisers Act of 1940, is
the beneficial owner of 830,830 shares or 7.29% of the common
stock outstanding of Utah Medical Products Incorporated ("the
Company") as a result of acting as investment adviser to
several investment companies registered under Section 8 of the
Investment Company Act of 1940.  

    Edward C. Johnson 3d, FMR Corp., through its control of
Fidelity, and the Funds each has sole power to dispose of the
830,830 shares owned by the Funds.

    Neither FMR Corp. nor Edward C. Johnson 3d, Chairman of FMR
Corp.,  has the sole power to vote or direct the voting of the
Shares owned directly by the Fidelity Funds, which power
resides with the Funds' Boards of Trustees.  Fidelity carries
out the voting of the Shares under written guidelines
established by the Funds' Boards of Trustees.

    Edward C. Johnson 3d owns 34.0% of the outstanding voting
common stock of FMR Corp.  Mr. Johnson 3d is Chairman of FMR
Corp.  Various Johnson family members and trusts for the
benefit of Johnson family members own FMR Corp. voting common
stock.  These Johnson family members, through their ownership
of voting common stock, form a controlling group with respect
to FMR Corp.



SCHEDULE 13G - TO BE INCLUDED IN STATEMENTS
FILED PURSUANT TO RULE 13d-1(b) or 13d-2(b)

RULE 13d-1(e)  AGREEMENT

    The undersigned persons, on February 11, 1994, agree and
consent to the joint filing on their behalf of this Schedule
13G in connection with their beneficial ownership of the common
stock of Utah Medical Products Incorporated at December 31,
1993.

    FMR Corp.
    By   /S/Arthur S. Loring
Arthur S. Loring
Vice President - Legal
         Edward C. Johnson 3d
    By   /S/Arthur S. Loring
Arthur S. Loring
Under Power of Attorney
dated 5/17/89
On File with Schedule
13G for
Airborne Freight Corp.
9/10/91
    Fidelity Management & Research
Company
    By   /S/Arthur S. Loring
Arthur S. Loring
Sr. V.P. and General
Counsel

</TEXT>
</DOCUMENT>
</IMS-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
